Topical delivery of hyaluronic acid into skin using SPACE-peptide carriers

被引:96
作者
Chen, Ming [1 ]
Gupta, Vivek [1 ]
Anselmo, Aaron C. [1 ]
Muraski, John A. [2 ]
Mitragotri, Samir [1 ]
机构
[1] Univ Calif Santa Barbara, Dept Chem Engn, Ctr Bioengn, Santa Barbara, CA 93106 USA
[2] Convoy Therapeut Inc, Oro Valley, AZ 85755 USA
基金
美国国家科学基金会;
关键词
Topical; Hyaluronan; Healing; Wound; Repair; Wrinkle; TRANSDERMAL DRUG-DELIVERY; HUMAN STRATUM-CORNEUM; DEFORMABLE LIPOSOMES; ELASTIC VESICLES; PHAGE DISPLAY; DOSAGE FORM; INTACT SKIN; IN-VITRO; ETHOSOMES; PERMEABILITY;
D O I
10.1016/j.jconrel.2013.10.007
中图分类号
O6 [化学];
学科分类号
070301 [无机化学];
摘要
Topical penetration of macromolecules into the skin is limited by their low permeability. Here, we report the use of a skin penetrating peptide, SPACE peptide, to enhance topical delivery of a macromolecule, hyaluronic acid (HA, MW: 200-325 kDa). The peptide was conjugated to phospholipids and used to prepare an ethosomal carrier system (similar to 110 nm diameter), encapsulating HA. The SPACE-ethosomal system (SES) enhanced HA penetration into porcine skin in vitro by 7.8+/- 1.1-fold compared to PBS. The system also enhanced penetration of HA in human skin in vitro, penetrating deep into the epidermis and dermis in skin of both species. In vivo experiments performed using SKH1 hairless mice also confirmed increased dermal penetration of HA using the delivery system; a 5-fold enhancement in penetration was found compared to PBS control. Concentrations of HA in skin were about 1000-fold higher than those in blood; confirming the localized nature of HA delivery into skin. The SPACE-ethosomal delivery system provides a formulation for topical delivery of macromolecules that are otherwise difficult to deliver into the skin. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:67 / 74
页数:8
相关论文
共 52 条
[1]
Testosterone ethosomes for enhanced transdermal delivery [J].
Ainbinder, D ;
Touitou, E .
DRUG DELIVERY, 2005, 12 (05) :297-303
[2]
America P.R.a.M.o, 2011, MED DEV SKIN DIS
[3]
[Anonymous], 1996, PART SIZ AN
[4]
Percutaneous penetration enhancement and its quantification [J].
Bach, M ;
Lippold, BC .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1998, 46 (01) :1-13
[5]
Foreword to Transdermal Delivery Mini Focus Issue [J].
Banga, Ajay K. .
THERAPEUTIC DELIVERY, 2012, 3 (03) :293-294
[6]
Bendas E.R., 2007, AAPS PHARMSCITECH, V8
[7]
Skin structure and mode of action of vesicles [J].
Bouwstra, JA ;
Honeywell-Nguyen, PL .
ADVANCED DRUG DELIVERY REVIEWS, 2002, 54 :S41-S55
[8]
AN INTERLABORATORY EVALUATION OF THE STIR-FLASK METHOD FOR THE DETERMINATION OF OCTANOL-WATER PARTITION-COEFFICIENTS (LOG POW) [J].
BROOKE, D ;
NIELSEN, I ;
DEBRUIJN, J ;
HERMENS, J .
CHEMOSPHERE, 1990, 21 (1-2) :119-133
[9]
Dermal and transdermal drug delivery systems: Current and future prospects [J].
Brown, MB ;
Martin, GP ;
Jones, SA ;
Akomeah, FK .
DRUG DELIVERY, 2006, 13 (03) :175-187
[10]
Hyaluronic acid: a unique topical vehicle for the localized delivery of drugs to the skin [J].
Brown, MB ;
Jones, SA .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2005, 19 (03) :308-318